Location History:
- Louisvillle, CO (US) (1999)
- Louisville, CO (US) (1993 - 2003)
- Thousand Oaks, CA (US) (2003 - 2004)
Company Filing History:
4 out of 1,975 
1 out of 11 
1 out of 1 Years Active: 1993-2004
Title: The Innovative Mind of Tadahiko Kohno
Introduction
Tadahiko Kohno is a prominent inventor based in Thousand Oaks, California, renowned for his contributions to the field of biotechnology. With a remarkable portfolio that includes seven patents, Kohno has made significant strides in developing novel pharmaceutical compounds.
Latest Patents
Among his latest inventions are the Apo-AI/AII peptide derivatives, which involve PEGylation reagents and compounds formed thereof. These compounds are characterized by the general formula R - X - R, where R and R denote biologically active groups, at least one of which is polypeptidic. The polymeric group X is non-peptidic, allowing R and R to either be identical or distinct, with a preference for R and R groups that act as TNF inhibitors.
Career Highlights
Throughout his career, Tadahiko Kohno has been associated with prominent biotechnology firms such as Amgen Inc. and Synergen, Inc. His work has shaped the direction of research and development in these companies, contributing to innovative solutions in therapeutics.
Collaborations
Kohno has also collaborated with distinguished colleagues such as Robert C. Thompson and Michael T. Brewer. These partnerships have fostered a productive environment for sharing ideas and advancing research in the biopharmaceutical domain.
Conclusion
Tadahiko Kohno stands out as a dedicated inventor whose work continues to influence the landscape of biopharmaceutical innovation. His patents reflect his commitment to developing effective treatments, particularly in the area of TNF inhibition. As biotechnology evolves, Kohno's contributions are likely to remain impactful in the advancement of therapeutic options.